Four integrated technologies for Biologics developability assessment

December 13, 2022

The decisions you make about your biologics candidates early in the pipeline ultimately affect their success as therapeutics.

Combine sizing and stability information to gain valuable insight into the viability of your protein-based biologic candidates, enabling you to select the best ones for further development.

The technologies inside the Prometheus Panta provide high-quality information about your candidates’ purity, size, thermal stability, and aggregation, which enables better pipeline decisions.

Learn more about how Prometheus Panta helps biologics researchers.

Previous Article
8 biologics conferences you won’t want to miss in 2023
8 biologics conferences you won’t want to miss in 2023

When you’re part of an industry that moves quickly, it’s important to keep up. You hear about biotherapeuti...

Up next
Top 8 biologics conferences of 2023 at a glance
Top 8 biologics conferences of 2023 at a glance

Use this downloadable list of 2023 biologics conferences to select which one to attend. Learn when and wher...

Ready to tackle your challenging stability characterizations?

Discover tools